• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of molecular mechanism of endochondral ossification targeting novel therapeutic strategy for skeletal dysplasia

Research Project

Project/Area Number 17590959
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Endocrinology
Research InstitutionKyoto University

Principal Investigator

YASODA Akihiro  Kyoto University, Graduate School of Medicine, assistant professor, 医学研究科, 助手 (50378642)

Co-Investigator(Kenkyū-buntansha) KOMATSU Yasato  Kyoto University, Graduate School of Medicine, part time lecturer, 医学研究科, 非常勤講師 (40322648)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2006: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2005: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsCNP-GC-B system / endochondral ossification / achondroplasia / FGF system / intracellular signaling
Research Abstract

Natriuretic peptide family consists of three endogenous ligands, ANP, BNP and CNP, and their membranous guanylyl cyclase receptors, GC-A and GC-B. We have shown that CNP-GC-B system is a strong stimulator of endochondral bone growth and that disturbed endochondral bone growth in mice model of achondroplastic with an activated FGFR3 in cartilage is greatly improved by activation of CNP-GC-B system. As for the mechanism, CNP/GC-B/cGMP restores the decreased cartilaginous matrix synthesis by inhibiting activation of MAPK pathway of FGF signaling.
In this project, further we investigated the intracellular signaling interaction between CNP-GC-B system and FGF system in cartilage. First we showed that FGF system stimulates both MAPK and STAT1 pathway and that CNP-GC-B system does not interfere to STAT1 pathway. We also showed that FGF signaling stimulates PI3/PKB pathway to which CNP-GC-B system interferes, and that PI3/PKB system is suppressed under the condition with heparin. On the other hand, activation of FGF pathway decreased the production of cGMP, the second messenger of CNP-GC-B system, dose-dependently. These results exhibit the reciprocal regulation of CNP-GC-B system and FGF system in cartilage.
Next we investigated local natriuretic peptide clearance system in cartilage by using fetal mice tibial organ culture system. Selective agonist for natriuretic peptide clearance receptor, C-ANF (4-23), elongated cultured fetal tibiae dose-dependently, and accordingly, we concluded that local natriuretic peptide clearance system works as one of the regulator of CNP-GC-B system in cartilage.

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (8 results)

All 2006 2005

All Journal Article (8 results)

  • [Journal Article] High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass.2006

    • Author(s)
      Natsui K, Tanaka K, Suda M, Yasoda A, Sakuma Y, Ozasa A, Ozaki S, Nakao K
    • Journal Title

      Osteoporos Int. 17

      Pages: 105-108

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription.2006

    • Author(s)
      Moriyama K, Tagami T, Usui T, Naruse M, Nambu T, Hataya Y, Kanamoto N, Li YS, Yasoda A, Arai H, Nakao K
    • Journal Title

      J Clin Endocrinol Metab. 92・3

      Pages: 1066-1072

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass.2006

    • Author(s)
      Natsui K, Tanaka K, Suda M, Yasoda A, Sakuma Y, Ozasa A, Ozaki S, Nakao K.
    • Journal Title

      Osteoporos Int. 17

      Pages: 105-108

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription.2006

    • Author(s)
      Moriyama K, Tagami T, Usui T, Naruse M, Nambu T, Hataya Y, Kanamoto N, Li YS, Yasoda A, Arai H, Nakao K.
    • Journal Title

      J Clin Endocrinol Metab. 92

      Pages: 1066-72

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription.2006

    • Author(s)
      Moriyama K, Tagami T, Usui T, Naruse M, Nambu T, Hataya Y, Kanamoto N, Li YS, Yasoda A, Arai H, Nakao K.
    • Journal Title

      J Clin Endocrinol Metab. 92・3

      Pages: 1066-1072

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Expression of the aderenomedullin gene in adipose tissue.2005

    • Author(s)
      Nambu T, Arai H, Komatsu Y, Yasoda A, Moriyama K, Kanamoto N, Itoh H, Nakao K
    • Journal Title

      Regul Pept 132

      Pages: 17-22

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Complementary antagonistic actions between C-Type natriuretic peptide and MAPK pathway through FGFR-3 in ATDC5 Cells.2005

    • Author(s)
      Ozasa A, Komatsu Y, Yasoda A, Miura M, Nakatsuru Y, Sakuma Y, Arai H, Itoh N, Nakao N
    • Journal Title

      Bone 36

      Pages: 1056-1064

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.2005

    • Author(s)
      Ozasa, et al.
    • Journal Title

      Bone 36・6

      Pages: 1056-1064

    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi